Robert Gut - Jun 13, 2023 Form 4 Insider Report for uniQure N.V. (QURE)

Role: Director
Signature: /s/ Christian Klemt, Attorney-in-Fact
Stock symbol: QURE
Transactions as of: Jun 13, 2023
Transactions value $: -$60,945
Form type: 4
Date filed: 6/20/2023, 05:20 PM
Previous filing: Mar 1, 2023
Next filing: Jun 17, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	QURE	Ordinary Shares	Award	$0	+8.7K	+20.62%	$0.00	50.9K	Jun 13, 2023	Direct	F1
transaction	QURE	Ordinary Shares	Sale	-$60.9K	-3.23K	-6.34%	$18.88	47.7K	Jun 16, 2023	Direct	F3, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	QURE	Stock Option (Right to Buy)	Award	$0	+17.1K		$0.00	17.1K	Jun 13, 2023	Ordinary Shares	17.1K	$20.18	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents restricted share units granted to the Reporting Person under the Issuer's 2014 Share Incentive Plan, as amended and restated. Each restricted share unit represents the contingent right to receive one Ordinary Share. The restricted share units vest 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date.
F2	The Stock Option vests 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date.
F3	As required by the relevant Restricted Share Unit Agreement, the Reporting Person sold the Ordinary Shares and remitted the proceeds therefrom to the Issuer to satisfy estimated tax withholding obligations triggered by the vesting of restricted share units.
F4	The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $18.85 to $18.92. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.